{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:40:50Z","timestamp":1721230850821},"reference-count":27,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14490","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T11:16:13Z","timestamp":1717586173000},"source":"Crossref","is-referenced-by-count":1,"title":["SMARCA4\u2011deficient uterine adnexal tumor with ascites: A case report and literature review"],"prefix":"10.3892","volume":"28","author":[{"given":"Xiu-Feng","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Weifang People's Hospital (First Affiliated Hospital of Shandong Second Medical University), Weifang, Shandong 261041, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People's Hospital (First Affiliated Hospital of Shandong Second Medical University), Weifang, Shandong 261041, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Changyi Maternal and Child Health Hospital, Changyi, Shandong 261300, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Jiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People's Hospital (First Affiliated Hospital of Shandong Second Medical University), Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People's Hospital (First Affiliated Hospital of Shandong Second Medical University), Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"key20240717175832_b1-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"762598","DOI":"10.3389\/fimmu.2021.762598","article-title":"A Pan-Cancer Analysis of SMARCA4 alterations in human cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"key20240717175832_b2-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-Deficient Sinonasal Carcinoma","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"key20240717175832_b3-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5858\/arpa.2019-0633-OA","article-title":"SMARCA4\/BRG1-Deficient non-small cell lung carcinomas: A case series and review of the literature","volume":"145","author":"Nambirajan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"key20240717175832_b4-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12328-022-01606-8","article-title":"The first case of SMARCA4-deficient sarcoma of stomach","volume":"15","author":"Ota","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"key20240717175832_b5-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13000-021-01091-6","article-title":"Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: A case report and literature review","volume":"16","author":"Duan","year":"2021","journal-title":"Diagn Pathol"},{"key":"key20240717175832_b6-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1016\/j.asjsur.2023.07.124","article-title":"SMARCA4-deficient dedifferentiated endometrioid carcinoma: A case report","volume":"46","author":"Huang","year":"2023","journal-title":"Asian J Surg"},{"key":"key20240717175832_b7-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","article-title":"A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation","volume":"20","author":"Michel","year":"2018","journal-title":"Nat Cell Biol"},{"key":"key20240717175832_b8-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1038\/s41388-021-01875-6","article-title":"SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer","volume":"40","author":"Kim","year":"2021","journal-title":"Oncogene"},{"key":"key20240717175832_b9-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1038\/s41598-018-20217-3","article-title":"High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer","volume":"8","author":"Guerrero-Mart\u00ednez","year":"2018","journal-title":"Sci Rep"},{"key":"key20240717175832_b10-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"key20240717175832_b11-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"key20240717175832_b12-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): A comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"key20240717175832_b13-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","article-title":"SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association","volume":"32","author":"Lin","year":"2019","journal-title":"Mod Pathol"},{"key":"key20240717175832_b14-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"15077","DOI":"10.3390\/ijms242015077","article-title":"Overview of tumor heterogeneity in high-grade serous ovarian cancers","volume":"24","author":"Azzalini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20240717175832_b15-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"153859","DOI":"10.1016\/j.prp.2022.153859","article-title":"Clinico-pathologic characteristics and prognostic factors of ovarian carcinoma with different histologic subtypes-A benchmark analysis of 482 cases","volume":"233","author":"Brambs","year":"2022","journal-title":"Pathol Res Pract"},{"key":"key20240717175832_b16-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2019.10.031","article-title":"Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts","volume":"157","author":"Connor","year":"2020","journal-title":"Gynecol Oncol"},{"key":"key20240717175832_b17-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): Clinical implications from recent molecular findings","volume":"10","author":"Lu","year":"2019","journal-title":"J Cancer"},{"key":"key20240717175832_b18-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13000-023-01347-3","article-title":"Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma","volume":"18","author":"Gao","year":"2023","journal-title":"Diagn Pathol"},{"key":"key20240717175832_b19-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"Witkowski","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20240717175832_b20-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cllc.2022.03.005","article-title":"Efficacy of immune checkpoint inhibitors in SMARCA4-Deficient thoracic tumor","volume":"23","author":"Shinno","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"key20240717175832_b21-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1177\/00031348221146972","article-title":"Identification and treatment of SMARCA4 deficient poorly differentiated gastric carcinoma","volume":"89","author":"Bhat","year":"2023","journal-title":"Am Surg"},{"key":"key20240717175832_b22-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.21037\/tcr-22-1679","article-title":"Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: A case report","volume":"12","author":"Yang","year":"2023","journal-title":"Transl Cancer Res"},{"key":"key20240717175832_b23-ol-28-2-14490","first-page":"100235","article-title":"Conversion surgery for advanced thoracic SMARCA4-Deficient undifferentiated tumor with atezolizumab in combination with bevacizumab, paclitaxel, and carboplatin treatment: A case report","volume":"2","author":"Kunimasa","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"key20240717175832_b24-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.adro.2021.100728","article-title":"Notable Response of SMARCA4-Deficient undifferentiated uterine sarcoma to palliative radiation therapy","volume":"6","author":"Kurokawa","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"key20240717175832_b25-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-021-24618-3","article-title":"SMARCA4 deficient tumours are vulnerable to KDM6A\/UTX and KDM6B\/JMJD3 blockade","volume":"12","author":"Romero","year":"2021","journal-title":"Nat Commun"},{"key":"key20240717175832_b26-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"778545","DOI":"10.3389\/fonc.2022.778545","article-title":"Clinical Benefit With PARP inhibitor for pathogenic germline FANCA-Mutated relapsed epithelial ovarian cancer: A case report","volume":"12","author":"Qian","year":"2022","journal-title":"Front Oncol"},{"key":"key20240717175832_b27-ol-28-2-14490","doi-asserted-by":"publisher","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T14:58:37Z","timestamp":1721228317000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14490","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"article-number":"357"}}